AN AUSTRALIAN Public Assessment Report (AusPAR) has been posted for Mayne Pharma's Ephedrine Hydrochloride, around approval of a major variation, namely a new strength of 25mg/mL.
Industry stakeholders welcome government announcement. Community pharmacists will be able to provide free flu vaccinations within…
Vital roles and contributions in healthcare made by outstanding pharmacists recognised. Last night in Perth, the…
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.